Recombinant Human TIMP2 protein is a Human Full Length protein, in the 27 to 220 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, HPLC.
Images
Key facts
- Purity
- >=95% SDS-PAGE
- Endotoxin level
- <= 0.005 EU/µg
- Expression system
- HEK 293 cells
- Tags
- Tag free
- Applications
- SDS-PAGE, MS, HPLC
- Biologically active
- No
Amino acid sequence
C S C S P V H P Q Q A F C N A D V V I R A K A V S E K E V D S G N D I Y G N P I K R I Q Y E I K Q I K M F K G P E K D I E F I Y T A P S S A V C G V S L D V G G K K E Y L I A G K A E G D G K M H I T L C D F I V P W D T L S T T Q K K S L N H R Y Q M G C E C K I T R C P M I P C Y I S S P D E C L W M D W V T E K N I N G H Q A K F F A C I K R S D G S C A W Y R G A A P P K Q E F L D I E D P
Reactivity data
| Application | Reactivity | Dilution info | Notes |
|---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Target data
Function
Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-13, MMP-14, MMP-15, MMP-16 and MMP-19.
Alternative names
Metalloproteinase inhibitor 2, CSC-21K, Tissue inhibitor of metalloproteinases 2, TIMP-2, TIMP2
Recommended products
Recombinant Human TIMP2 protein is a Human Full Length protein, in the 27 to 220 aa range, expressed in HEK 293, with >=95% purity, <= 0.005 EU/µg endotoxin level and suitable for SDS-PAGE, MS, HPLC.
Key facts
- Purity
- >=95% SDS-PAGE
- Endotoxin level
- <= 0.005 EU/µg
- Expression system
- HEK 293 cells
- Tags
- Tag free
- Applications
- SDS-PAGE, MS, HPLC
- Biologically active
- No
- Accession
- P16035-1
- Animal free
- Yes
- Carrier free
- Yes
- Species
- Human
- Reconstitution
- Reconstitute in PBS
- Concentration
- Storage buffer
pH: 7.4
Constituents: 10.26% Trehalose, 0.727% Dibasic monohydrogen potassium phosphate, 0.248% Potassium phosphate monobasic
Sequence info
Amino acid sequence
- C S C S P V H P Q Q A F C N A D V V I R A K A V S E K E V D S G N D I Y G N P I K R I Q Y E I K Q I K M F K G P E K D I E F I Y T A P S S A V C G V S L D V G G K K E Y L I A G K A E G D G K M H I T L C D F I V P W D T L S T T Q K K S L N H R Y Q M G C E C K I T R C P M I P C Y I S S P D E C L W M D W V T E K N I N G H Q A K F F A C I K R S D G S C A W Y R G A A P P K Q E F L D I E D P
- Accession
- P16035
- Protein length
- Full Length
- Predicted molecular weight
- 21.81 kDa
- Actual molecular weight
- 21.81 kDa
- Amino acids
- 27 to 220
- Nature
- Recombinant
Specifications
- Form
- Lyophilized
- Additional notes
Purity by HPLC >=95%
General info
- Function
Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. Known to act on MMP-1, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9, MMP-10, MMP-13, MMP-14, MMP-15, MMP-16 and MMP-19.
- Sequence similarities
Belongs to the protease inhibitor I35 (TIMP) family.
- Post-translational modifications
The activity of TIMP2 is dependent on the presence of disulfide bonds.
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- Ambient
- Appropriate long-term storage conditions
- Ambient
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
TIMP2 also known as Tissue Inhibitor of Metalloproteinases 2 mechanistically inhibits the activity of matrix metalloproteinases (MMPs). It binds to MMPs regulating the extracellular matrix's remodeling. The protein has a molecular mass of around 21 kDa. TIMP2 is expressed in various tissues including the brain liver and kidneys where it maintains a balance between matrix degradation and production.
- Biological function summary
TIMP2 plays a significant role in tissue maintenance and repair by controlling extracellular matrix turnover. It forms complexes with MMPs such as MMP-2 inhibiting their proteolytic activities. The protein is also involved in cell proliferation and differentiation affecting processes like angiogenesis and wound healing. Its regulatory function aids in maintaining tissue homeostasis and preventing excessive matrix breakdown.
- Pathways
TIMP2 is integral to the matrix metalloproteinase pathway and the regulation of endothelial cell migration. The protein interacts closely with other MMPs influencing their activation and modulation. Through these pathways TIMP2 holds an important position in cellular migration and signaling ensuring precise matrix remodeling in response to physiological needs.
- Associated diseases and disorders
TIMP2 has significant links with cancer and fibrosis. Dysregulation of TIMP2 expression or its imbalance with MMPs can contribute to tumor progression and metastasis due to uncontrolled matrix degradation. Additionally abnormal TIMP2 levels associate with fibrotic diseases where excessive tissue deposition occurs. TIMP2's interaction with proteins like MMP-9 and MMP-2 highlights its involvement in these pathological conditions.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
3 product images
SDS-PAGE - Recombinant Human TIMP2 protein (ab287940)
SDS-PAGE analysis of ab287940
Mass Spectrometry - Recombinant Human TIMP2 protein (ab287940)
ESI-TOF analysis ab287940.
Predicted MW is 21812.05 Da (+/- 1-0 Da by ESI TOF). Observed MW is 21812.41 Da.
HPLC - Recombinant Human TIMP2 protein (ab287940)
HPLC analysis of ab287940.
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com